ChemAxon has announced agreement with Prous Science for the provision of ChemAxon's JChem Cartridge cheminformatics suite and Marvin, its Java-based structure editor and viewer, for Prous Science web-based content products.
The agreement outlines the use of ChemAxon software initially within the Prous Science Integrity® drug discovery and development portal.
Based entirely in Java, the suite is platform-independent, and for Marvin, the structure editor and viewer element, means straightforward browser-based operation for online interaction and delivery.
As a resource for empowering drug R&D activities and following the progress of chemical entities through the discovery and development pipeline, Prous Science Integrity® reflects trends in pharmaceutical and biotech research during the last 25 years.
Integrity®'s 220,000 compounds offer comprehensive coverage of the significant discoveries in modern medicinal chemistry and biology as related to drugs and therapeutics, along with a range of powerful tools to search, filter and find relationships within the extensive content available.
Along with basic product information, Integrity® offers a wide array of complementary data on experimental pharmacology, pharmacokinetics, organic synthesis and targets, among other fields, allowing investigators to originate hypotheses in the discovery and development of better and safer drugs.
The addition of the JChem suite functionality to the Integrity® portal, now available, designed to offer users options for structure searching.
The integration of Marvin allows users to build complex, structure-based queries directly from their browser window without the need for special plugins or user native software.
Dr. Ferenc Csizmadia, CEO of ChemAxon, said, "We are happy to be working with Prous Science, particularly in the area of knowledge-driven discovery. It's a good fit."
"The addition of the JChem suite provides enhanced chemistry awareness within Integrity®, giving users an extensive range of chemistry options directly from their desktop," said Dr. Josep Prous, Jr., Executive Vice President of Prous Science.